These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33464392)

  • 41. Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.
    Ørnbjerg LM; Østergaard M; Jensen T; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Hetland ML; ; Slot O; Nielsen LK; Skjødt H; Majgaard O; Lorenzen T; Horn HC; Kowalski M; Johansen IL; Pedersen PM; Manilo N; Bliddal H
    Clin Rheumatol; 2017 Apr; 36(4):781-789. PubMed ID: 27921185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis.
    Carbone LD; Kaeley G; McKown KM; Cremer M; Palmieri G; Kaplan S
    Calcif Tissue Int; 1999 Feb; 64(2):100-1. PubMed ID: 9914314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population.
    Haugeberg G; Ørstavik RE; Uhlig T; Falch JA; Halse JI; Kvien TK
    Osteoporos Int; 2003 Jun; 14(4):312-9. PubMed ID: 12730749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Favourable effect of a 'second hit' after 13 weeks in early RA non-responders: the Amsterdam COBRA treat-to-target randomized trial.
    Hartman L; Rasch LA; Turk SA; Ter Wee MM; Kerstens PJSM; van der Laken CJ; Nurmohamed MT; van Schaardenburg D; van Tuyl LHD; Voskuyl AE; Boers M; Lems WF
    Rheumatology (Oxford); 2023 Jun; 62(6):2098-2105. PubMed ID: 36205538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.
    Wevers-de Boer KV; Heimans L; Visser K; Kälvesten J; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman M; de Buck MP; de Sonnaville PB; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2015 Feb; 74(2):341-6. PubMed ID: 24285491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
    Chen YM; Chen HH; Huang WN; Liao TL; Chen JP; Chao WC; Lin CT; Hung WT; Hsieh CW; Hsieh TY; Chen YH; Chen DY
    PLoS One; 2017; 12(11):e0188454. PubMed ID: 29155868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates.
    Nagashima M; Takahashi H; Shimane K; Nagase Y; Wauke K
    Arthritis Res Ther; 2012 Oct; 14(5):R224. PubMed ID: 23079134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study.
    di Munno O; Mazzantini M; Sinigaglia L; Bianchi G; Minisola G; Muratore M; la Corte R; di Matteo L; Canesi B; Caminiti M; Broggini M; Adami S
    J Rheumatol; 2004 Jul; 31(7):1305-9. PubMed ID: 15229948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.
    Engvall IL; Tengstrand B; Brismar K; Hafström I
    Arthritis Res Ther; 2010; 12(5):R197. PubMed ID: 20964833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-analysis suggests that intensive non-biological combination therapy with step-down prednisolone (COBRA strategy) may also 'disconnect' disease activity and damage in rheumatoid arthritis.
    Boers M; van Tuyl L; van den Broek M; Kostense PJ; Allaart CF
    Ann Rheum Dis; 2013 Mar; 72(3):406-9. PubMed ID: 23155223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sulfasalazine treatment but not with sex hormones.
    Tengstrand B; Hafström I
    J Rheumatol; 2002 Nov; 29(11):2299-305. PubMed ID: 12415584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Kipen Y; Briganti E; Strauss B; Will R; Littlejohn G; Morand E
    J Rheumatol; 1999 Feb; 26(2):310-7. PubMed ID: 9972964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women.
    Hall GM; Spector TD; Griffin AJ; Jawad AS; Hall ML; Doyle DV
    Arthritis Rheum; 1993 Nov; 36(11):1510-6. PubMed ID: 8240428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between Bone Mineral Density of Femoral Neck and Geriatric Nutritional Risk Index in Rheumatoid Arthritis Patients Treated with Biological Disease-Modifying Anti-Rheumatic Drugs.
    Tokumoto H; Tominaga H; Arishima Y; Jokoji G; Akimoto M; Ohtsubo H; Taketomi E; Sunahara N; Nagano S; Ishidou Y; Komiya S; Setoguchi T
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29463015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conventional synthetic disease-modifying antirheumatic drugs and bone mineral density in rheumatoid arthritis patients with osteoporosis: possible beneficial effect of leflunomide.
    Kwon OC; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
    Clin Exp Rheumatol; 2019; 37(5):813-819. PubMed ID: 30767868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score.
    Bréban S; Briot K; Kolta S; Paternotte S; Ghazi M; Fechtenbaum J; Roux C
    J Clin Densitom; 2012; 15(3):260-6. PubMed ID: 22445857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Combination therapy in early rheumatoid arthritis: the COBRA study].
    Boers M; Verhoeven AC; van der Linden S
    Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study.
    Mazzantini M; Di Munno O; Sinigaglia L; Bianchi G; Rossini M; Mela Q; Del Puente A; Frediani B; Cantatore F; Adami S
    Clin Exp Rheumatol; 2007; 25(5):709-15. PubMed ID: 18078618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis.
    Boers M; Kostense PJ; Verhoeven AC; van der Linden S;
    Arthritis Rheum; 2001 Oct; 44(10):2242-6. PubMed ID: 11665964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study.
    Kröger H; Honkanen R; Saarikoski S; Alhava E
    Ann Rheum Dis; 1994 Jan; 53(1):18-23. PubMed ID: 8311549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.